This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When operational in early 2025, the new facility will be the first commercial biopharma manufacturing facility to incorporate the latest manufacturing technologies along with in-house processimprovements for increased flexibility, speed and output under one roof.
In this article, well explore the key trends, technologies, and challenges shaping the pharma marketing world today. Technologies like AI, big data, and AR/VR streamline processes, improve targeting, and create more engaging campaigns. How can technology enhance pharma marketing strategies?
In this article, we’ll explore some innovations and improvement opportunities in the science, manufacturing processes, and facilities that produce these therapies. Combining the incremental processimprovements previously mentioned results in an optimized facility, with the adjusted block flow shown in Figure 5.
Streamlining processes, improving digital tools, and creating a smooth overall experience are essential steps to keeping patients from looking elsewhere. Boost Patient Satisfaction with Viseven Throughout this article, you’ve probably noted a few ideas on how you can get more satisfied patients at your organization.
This article summarizes an alternate and more functional way to format the QOS presented in Module 2.3. For purpose of illustration used throughout this article, labels have been assigned to each CQA. The summary included the concepts outlined in this article and aimed to clearly convey the product control strategy.
This article summarizes an alternate and more functional way to format the QOS presented in Module 2.3. For purpose of illustration used throughout this article, labels have been assigned to each CQA. The summary included the concepts outlined in this article and aimed to clearly convey the product control strategy.
This article presents relevant insights on the current regulatory and technical landscape for decentralized manufacturing, with select examples of current applications, and discusses perspectives on evolving and adapting the current regulations to meet future capabilities. Product Focus: Advancing Aseptic Processing.” 5 October 2022.
Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. US Food and Drug Administration.
In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). This article highlights the regulatory expectations of raw materials, the challenges of postapproval changes. and the impact on supply resiliency. 11 Ahluwalia, K., Abernathy, J.
linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). Process Intensification in the Biopharma Industry: Improving Efficiency of Protein Manufacturing Processes from Development to Production Scale Using Synergistic Approaches.”
These long global approval timelines complicate supply chain management by delaying innovations that improve quality assurance and by increasing the potential for supply interruptions and shortages that impact patient access to products.
” Jeff Cruz Looking ahead, AI will likely evolve into niche applications that address specific stages of the M&A process, improving efficiency while maintaining the need for human expertise in more strategic areas. This is something firms will need to navigate carefully.”
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content